WuXi PharmaTech (WX) stock briefly hit a five-year high on the stock market Wednesday after the China-based clinical research organization beat analysts’ Q3 earnings estimates, but then pulled back. Late Tuesday, WuXi reported earnings of 47 cents a share, up 31% from the year-earlier quarter and 8 cents past analysts’ consensus. Revenue rose 17% to $146.7 million, about $1 million more than expected. The company raised the low end of its
Visit site:
WuXi Stock Seesaws After Q3 Earnings, Guidance Beat